8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.

A Novel Method for Achieving Precision and Reproducibility in a 1

Bioeffects Seen

Authors not listed · 2025

Share:

New portable biosensor technology could revolutionize real-time biological monitoring in EMF research.

Plain English Summary

Summary written for general audiences

Researchers developed two methods for measuring clarithromycin antibiotic levels in blood plasma - a traditional lab technique and a new portable sensor. Both methods achieved the same detection accuracy, but the portable sensor works in under 30 minutes compared to longer lab processing times. This represents progress toward faster, point-of-care medical testing that could improve patient monitoring.

Why This Matters

While this study focuses on antibiotic detection rather than EMF effects, it highlights an important principle in biomedical research - the need for multiple analytical approaches to validate findings. The electrochemical immunosensor technology described here represents the kind of rapid, portable testing that could revolutionize how we monitor biological responses to EMF exposure. Currently, most EMF health research relies on traditional laboratory methods that require significant time and resources, limiting our ability to conduct real-time exposure monitoring. The development of point-of-care biosensors could transform EMF research by enabling continuous monitoring of biomarkers during actual exposure scenarios, rather than relying solely on controlled laboratory conditions that may not reflect real-world EMF environments.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2025). A Novel Method for Achieving Precision and Reproducibility in a 1.
Show BibTeX
@article{a_novel_method_for_achieving_precision_and_reproducibility_in_a_1_ce2347,
  author = {Unknown},
  title = {A Novel Method for Achieving Precision and Reproducibility in a 1},
  year = {2025},
  doi = {10.1007/s00604-025-07652-6},
  
}

Quick Questions About This Study

Electrochemical immunosensors use functionalized magnetic beads and screen-printed electrodes to provide rapid results in under 30 minutes, compared to traditional chromatography methods that require longer processing times and centralized laboratory facilities.
Both methods achieved identical detection limits of 0.03 µg/mL with excellent linearity and precision. The portable immunosensor matched the performance of the established LC-MS/MS laboratory technique while offering faster results.
Both analytical methods demonstrated robust performance across a validated concentration range of 0.1 to 4.0 µg per milliliter in human plasma samples, covering clinically relevant therapeutic drug monitoring levels.
Functionalized magnetic beads enable selective capture and concentration of target molecules from complex biological samples like blood plasma, improving detection specificity and reducing interference from other compounds present in the sample.
Yes, the electrochemical immunosensor demonstrated high selectivity even in complex biological matrices like human plasma, maintaining accuracy despite the presence of proteins, cells, and other interfering substances.